High Throughput Screening to Identify Selective and Nonpeptidomimetic Proteasome Inhibitors As Antimalarials-Reference-Cited by-同舟云学术

High Throughput Screening to Identify Selective and Nonpeptidomimetic Proteasome Inhibitors As Antimalarials

Published:2021-05-28 Issue:6 Volume:7 Page:1818-1832
ISSN:2373-8227
Container-title:ACS Infectious Diseases
language:en
Short-container-title:ACS Infect. Dis.

Author:

Mata-Cantero Lydia¹^ORCID,Xie Stanley C.²^ORCID,García Mercedes³,Coyle Joanne²,Fernandez Raquel³,Cabrera Alvaro Cortes³^ORCID,Gillett David L.²,Crespo Benigno¹,Gamo Francisco-Javier¹^ORCID,Fernández Esther¹^ORCID,Tilley Leann²^ORCID,Gomez-Lorenzo Maria G.¹^ORCID

Affiliation:

1. Global Health Discovery Incubator Unit, Global Health R&D. GlaxoSmithKline. Severo Ochoa 2, Tres Cantos 28760, Madrid Spain

2. Department of Biochemistry and Pharmacology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, 30 Flemington Road, Melbourne, Victoria 3010, Australia

3. MST-MedDesign-MedChem R&D. GlaxoSmithKline. Severo Ochoa 2, Tres Cantos 28760, Madrid Spain

Funder

Tres Cantos Open Lab Foundation (TCOLF)

Australian National Health and Medical Research Council

Publisher

American Chemical Society (ACS)

Subject

Infectious Diseases

Link

https://pubs.acs.org/doi/pdf/10.1021/acsinfecdis.1c00110

Reference41 articles.

1. WHO. 2019. World Malaria Report.

2. Antimalarial drug resistance: new treatments options for Plasmodium

3. Assembly, structure, and function of the 26S proteasome

4. New insights into host-parasite ubiquitin proteome dynamics in P. falciparum infected red blood cells using a TUBEs-MS approach

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and future perspectives of noncompetitive proteasome inhibitors;Bioorganic Chemistry;2023-06

2. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome;Cell Chemical Biology;2023-05

3. A comprehensive review on classifying fast-acting and slow-acting antimalarial agents based on time of action and target organelle of Plasmodium sp;Pathogens and Disease;2022